Termination Decision Document | Aug 21, 2020 | PAPER | BOARD |
Patent Owners' Joint Amended Mandatory Notices | Aug 11, 2020 | PAPER | PATENT OWNER |
Patent Owners' Joint Amended Mandatory Notices | Jun 30, 2020 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Jun 26, 2020 | PAPER | PETITIONER |
Hearing Transcript | May 27, 2020 | PAPER | BOARD |
Nalox1251 | May 8, 2020 | EXHIBIT | PETITIONER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S
UPDATED EXHIBIT LIST | May 8, 2020 | PAPER | PETITIONER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿s
MOTION FOR OBSERVATIONS ON THE SECOND DEPOSITION OF
PATENT OWNERS¿¿¿ EXPERT DR. STUART ALLEN JONES | May 8, 2020 | PAPER | PETITIONER |
Trial Order | Apr 28, 2020 | PAPER | BOARD |
Ex. 2215 Donovan April 17, 2020 Transcript | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2216 San Francisco EMS Manual (Hochhaus 1) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2217 Seal 2005 (Hochhaus 2) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2219 Skoog (Hochhaus 4) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2214 Hochhaus April 14, 2020 Transcript | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2218 Hochhaus PK Model Website (Hochhaus 3) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2220 Hochhaus Demonstrative with Incorrect Equation (Hochhaus 5) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2221 Hochhaus Exhibit 6 Nalox1252 EXHIBIT E | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2222 Hochhaus Exhibit 7 (Altman 2005) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2223 EXHIBIT E (corrected with standard errors) | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2301 - Yoshioka & Stella 2002 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2303 - Pifferi 1999 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2305 - Baertschi 2005 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2306 - Felton 2012 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2307 - Broxton 1984 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2309 - Tsuji 1982 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2314 - Turro 1979 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2315 - Handa 2014 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2317 - Parikh 2011 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2320 - Sacha 2010 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2302 - Alsante 2007 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2304 - Mollica 1978 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2308 - Samiey 2014 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2310 - HPE Cetrimide | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2311 - Prapaitrakul 1985 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2312 - Matheson 1978 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2313 - Geiger 1975 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2316 - Okano 2000 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2318 - Jenke 2014 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2319 - Yu 2010 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2322 - Vedrine 2017 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2321 - Guess 1962 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Ex. 2323 - Borchert 1989 | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Patent Owners' Surreply | Apr 24, 2020 | PAPER | PATENT OWNER |
Ex. 2300 - Supplemental Declaration of Stuart A. Jones, Ph.D. | Apr 24, 2020 | EXHIBIT | PATENT OWNER |
Patent Owners' Exhibit List | Apr 24, 2020 | PAPER | PATENT OWNER |
Petitioner's Second Notice of Deposition of Dr. Stuart Allen Jones | Apr 20, 2020 | PAPER | PETITIONER |
Joint Notice of Stipulation Regarding Scheduling | Apr 10, 2020 | PAPER | PATENT OWNER |
Patent Owners' Second Notice of Deposition of Gunther Hochhaus, Ph.D. | Apr 7, 2020 | PAPER | PATENT OWNER |
Patent Owners' Second Notice of Deposition of Maureen Donovan, Ph.D. | Apr 7, 2020 | PAPER | PATENT OWNER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC's REQUEST FOR ORAL ARGUMENT | Apr 6, 2020 | PAPER | PETITIONER |
Patent Owners' Request for Oral Argument | Apr 6, 2020 | PAPER | PATENT OWNER |
Joint Notice of Stipulation Regarding Scheduling | Mar 27, 2020 | PAPER | PATENT OWNER |
Patent Owners' Objections to Petitioner's Reply Evidence | Mar 19, 2020 | PAPER | PATENT OWNER |
Nalox1203 AHRQ (2017) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1204 Asali (1984) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1208 Connors (1986) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1211 2015 FDA Meeting | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1215 Hochhaus (1995) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1216 Hochhaus (2002) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1217 Hochhaus (1997) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1222 Kanaan (2009) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1223 Kerensky (2017) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1226 Kreiter (2016) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1227 Marx (2015) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1230 Pace (1979) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1233 Sporer (1996) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1236 Suzuki (2010) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1241 Yu (2014) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1243 ASTEPRO | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1250 Lemiuex | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1206 Bures (2019) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1207 Pediatrics (1990) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1210 Ehrick (2013) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1213 2009 FDA Guidance | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1214 Hiom (2004) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1218 Hsu (2019) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1219 FDA B Names | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1220 FDA FAQ | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1221 Jambhekar (2009) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1224 Kim (1997) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1225 Kreiter (2019) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1228 Melichar (2003) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1229 Mueller (2015) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1231 Quarry (2002) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1234 Suarez (1998) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1235 Sugano (2009) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1237 Talton (2000) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1238 Wanger (1998) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1239 Weinstein (1973) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1240 Yeh (1961) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1242 Zuckerman (2014) | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1244 PATANASE | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1245 NASACORT | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1246 FLONASE | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1247 XHANCE | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1248 Jones Deposition Transcript | Mar 12, 2020 | EXHIBIT | PETITIONER |
Nalox1249 HPE Potassium Sorbate (2009) | Mar 12, 2020 | EXHIBIT | PETITIONER |
SUPPLEMENTAL DECLARATION OF MAUREEN DONOVAN, Ph.D. | Mar 12, 2020 | EXHIBIT | PETITIONER |
SUPPLEMENTAL DECLARATION OF GUNTHER HOCHHAUS, Ph.D. | Mar 12, 2020 | EXHIBIT | PETITIONER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC'S REPLY TO PATENT OWNERS' RESPONSE | Mar 12, 2020 | PAPER | PETITIONER |
JOINT NOTICE OF STIPULATION REGARDING SCHEDULING | Mar 6, 2020 | PAPER | PETITIONER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S NOTICE OF DEPOSITION OF DR. STUART ALLEN JONES | Feb 3, 2020 | PAPER | PETITIONER |
Order Additional Discovery | Jan 21, 2020 | PAPER | BOARD |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S OBJECTIONS TO
EVIDENCE SUBMITTED WITH THE PATENT OWNER RESPONSE
PURSUANT TO 37 C.F.R. ¿¿ 42.64(B)(1) | Jan 8, 2020 | PAPER | PETITIONER |
Motion to Seal - 688 | Dec 23, 2019 | PAPER | PATENT OWNER |
Ex. 2102. Module 3.2.P.5.1 Specifications (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2104. Module 3.2.P.8.3 Stability Data (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2107. Module 2.7.1 Summary of Biopharmaceutics Studies (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2109. Validation Report for SMA 73.7822 (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2105. Clinical Study Report (PROTECTIVE ORDER MATERIAL)_Part4 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2098. Module 2.3.P.1 Description and Composition of Drug Product (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2099. Module 2.3.P.5 Control of Drug Product (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2100. Module 2.3.P.7 Container Closure System (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2101. Module 2.6.1 Nonclinical Introduction (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2103. Module 3.2.P.8.1 Stability Summary (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2106. Module 3.2.P.3.4 Control of Critical Steps (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2108. Module 2.7.6 Synopsis of Individual Studies (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2105. Clinical Study Report (PROTECTIVE ORDER MATERIAL)_Part1 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2105. Clinical Study Report (PROTECTIVE ORDER MATERIAL)_Part2 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2105. Clinical Study Report (PROTECTIVE ORDER MATERIAL)_Part3 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2188. Indivior NDA Module 3.2.P.2 (PROTECTIVE ORDER MATERIAL) | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2203. Begres IPR Declaration - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2201. Jones IPR Declaration - PROTECTIVE ORDER MATERIAL - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2202. Williams IPR Declaration - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2204. Karas IPR Declaration - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2205. Vigil IPR Declaration - PROTECTIVE ORDER MATERIAL - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2206. Vigil IPR Declaration - REDACTED - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2207. Brides IPR Declaration - PROTECTIVE ORDER MATERIAL - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2208. Jones IPR Declaration - REDACTED - 688 | Dec 23, 2019 | EXHIBIT | PATENT OWNER |
Exhibit List - 688 | Dec 23, 2019 | PAPER | PATENT OWNER |
Patent Owners' Response | Dec 23, 2019 | PAPER | PATENT OWNER |
Ex. 2069. Bechgaard | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2071. Bommer | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2075. Davis | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2067. Altannak | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2068. Aungst | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2070. Bernstein | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2073. Chiodini | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2076. EMA Guideline on Excipients | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2077. EMA Presentation | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2079. European Pharmacopoeia 8.0 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2080. Harm Reduction Coalition | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2082. Hofmann | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2087. Merkus | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2081. Ho | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2083. IMS Naloxone HCl Label | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2089. Nyxoid Assessment Report | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2090. Okada 1983 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2091. Pfeiffer Nasal Delivery | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2088. Migranal Label | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2095. Wang 2012 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2097. Narcan Nasal Spray Highlights of Presc. Info. | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2114. Adapt Fact Sheet | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2115. Adapt Flier | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2116. Adapt Website | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2118. UMass Naloxone Pricing Guide | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2122. Narcan Nasal Spray Label | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2124. Adapt Priority Review | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2092. Quadir | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2093. Remington | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2094. Suman | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2096. WHO Guide | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2113. Adapt Brochure | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2117. Prescribe to Prevent | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2119. Surgeon General Advisory | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2120. Narcan(R) Nasal Spray Consumer FAQs | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2121. How to Get Narcan(R) Nasal Spray | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2123. Adapt Fast Track | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2125. Adapt Narcan(R) Nasal Spray Approved | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2126. Adapt Narcan(R) Nasal Spray Available | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2131. Kaleo Evzio2You | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2135. Senate Evzio(R) Report | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2136. FDA Narcan(R) Nasal Spray Approved | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2138. FDA Evzio(R) 2 mg Orange Book | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2140. NIDA Narcan(R) Nasal Spray Approved | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2141. Wisconsin DOJ | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2144. PAARI About Us | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2148. Intranasal.net Links | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2149. Intranasal.net Opiate Overdose | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2152. Attorney General Coffman | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2153. Attorney General Mills | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2154. Lake County Health Department | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2155. Davenport Fire Department | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2157. Peoria Police Department | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2158. Martin County Sheriff's Office | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2160. Coventry Police Department | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2127. Emergent Adapt Acquisition | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2128. Kaleo Evzio(R) Approved | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2129. Kaleo Evzio(R) Available | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2130. Kaleo About Evzio(R) | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2132. Kaleo Cares | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2133. Kaleo Authorized Generic | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2134. Kaleo Public Access | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2137. FDA Evzio(R) 2 mg Summary Review | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2142. Delaware County | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2143. Somerset County | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2145. PAARI Partners | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2146. Harvard Pilgrim About Us | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2147. Harvard Pilgrim Coverage | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2150. NACo Press Release | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2151. Governor Wolf | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2156. Stafford County Fire & Rescue | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2159. Upper Darby Police Department | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2162. Brunswick County Board of Education | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2164. WSJ Overdose Deaths | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2166. Berndt 1994 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2167. Berndt 2001 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2168. Venkataraman | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2170. Mogelefsky | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2173. Indivior Presentation | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2174. Novus Detox | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2179. Weber 2012 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2180. Leavitt 2010 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2181. FDA Fast Track | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2182. Edwards 2015 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2183. Merlin 2015 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2184. Chad | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2191. Enteen | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2161. Smoky Mountain News | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2163. Pennsylvania Department of Health | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2165. Guha | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2169. PhRMA | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2171. Mizik | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2172. OINDPnews Indivior Submission | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2178. Email Narcan Nasal Spray -- IPR Request | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2185. Rosen | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2186. Kim | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2187. HRC 2012 Guide_ | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2189. Amphastar 10-K) | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2190. US9561177 | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2194. Indivior Subpoena | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2192. Seal | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2193. Clarke | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2195. Indivior Subpoena Response | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2196. Indivior Production Email | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2197. Bloomberg Symphony FAQs | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2198. AntiOp Agreement Press Release | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2199. Certified Translation of Verse | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2200. Jones CV | Dec 20, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2042. Euerby | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2045. Hospira Naloxone HCl Label | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2050. Verse | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2052. Donovan Alcon Deposition | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2055. Kabara | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2060. Hochhaus Handbook Transcript | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2062. Hochhaus Diagram | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2040. Iowa Library | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2041. Ansels | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2043. Hodges | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2044. Meda Transcript | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2046. Evzio(R) Label | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2047. Imitrex Label | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2048. Zomig Label | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2049. Rizzo | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2051. European Pharmacopoeia 6.0 | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2053. Donovan Alcon Report | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2054. AHFS | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2059. Spruill - Part 1 | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2059. Spruill - Part 2 | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2061. Muller | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2065. Donovan Nov. 22, 2019 Transcript | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Ex. 2066. Hochhaus Dec. 6, 2019 Transcript | Dec 19, 2019 | EXHIBIT | PATENT OWNER |
Joint Notice of Stipulation Regarding Scheduling | Dec 18, 2019 | PAPER | PATENT OWNER |
JOINT AMENDED MANDATORY NOTICES OF PATENT OWNERS ADAPT PHARMA OPERATIONS LIMITED AND OPIANT PHARMACEUTICALS, INC. | Dec 17, 2019 | PAPER | PATENT OWNER |
ORDER Granting Patent Owners' Motions to Withdraw and Substitute Counsel | Dec 5, 2019 | PAPER | BOARD |
PATENT OWNERS UNOPPOSED MOTION TO WITHDRAW AND SUBSTITUTE COUNSEL | Nov 26, 2019 | PAPER | PATENT OWNER |
POWER OF ATTORNEY FOR OPIANT PHARMACEUTICALS, INC. | Nov 26, 2019 | PAPER | PATENT OWNER |
ORDER
Conduct of Proceeding
37 C.F.R. ¿¿ 42.5 | Nov 25, 2019 | PAPER | BOARD |
PANEL CHANGE ORDER
Conduct of the Proceedings
37 C.F.R. ¿¿ 42.5 | Nov 21, 2019 | PAPER | BOARD |
DECISION
Granting Patent Owner Adapt Pharma Operations Limiteds
Motion for Pro Hac Vice Admission of Ana C. Reyes
37 C.F.R. 42.10 | Nov 21, 2019 | PAPER | BOARD |
PATENT OWNERS NOTICE OF DEPOSITION OF DONOVAN | Nov 20, 2019 | PAPER | PATENT OWNER |
PATENT OWNERS NOTICE OF DEPOSITION OF HOCHHAUS | Nov 20, 2019 | PAPER | PATENT OWNER |
DECLARATION OF ANA C. REYES IN SUPPORT OF MOTION FOR PRO HAC VICE ADMISSION PURSUANT TO 37 C.F.R. sec. 42.10(c) | Nov 19, 2019 | EXHIBIT | PATENT OWNER |
JOINT AMENDED MANDATORY NOTICES OF PATENT OWNERS ADAPT PHARMA OPERATIONS LIMITED AND OPIANT PHARMACEUTICALS, INC. | Nov 19, 2019 | PAPER | PATENT OWNER |
POWER OF ATTORNEY FOR PATENT OWNER ADAPT PHARMA OPERATIONS LIMITED | Nov 19, 2019 | PAPER | PATENT OWNER |
UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ANA C. REYES PURSUANT TO 37 C.F.R. sec. 42.10(c) | Nov 19, 2019 | PAPER | PATENT OWNER |
PATENT OWNERS NOTICE OF DEPOSITION OF DONOVAN | Nov 6, 2019 | PAPER | PATENT OWNER |
PATENT OWNERS NOTICE OF DEPOSITION OF HOCHHAUS | Nov 6, 2019 | PAPER | PATENT OWNER |
Amended Joint Notice of Stipulation Regarding Schedule | Oct 30, 2019 | PAPER | PATENT OWNER |
Joint Notice of Stipulation Regarding Scheduling | Oct 25, 2019 | PAPER | PATENT OWNER |
Patent Owners Objections to Evidence | Sep 23, 2019 | PAPER | PATENT OWNER |
PETITIONER NALOX-1 PHARMACEUTICALS, LLC¿¿¿S OBJECTIONS TO EVIDENCE SUBMITTED DURING THE PRELIMINARY PROCEEDING PURSUANT TO 37 C.F.R. ¿¿ 42.64(B)(1) | Sep 20, 2019 | PAPER | PETITIONER |
Decision Institution of Inter Partes Review | Sep 9, 2019 | PAPER | BOARD |
SCHEDULING ORDER | Sep 9, 2019 | PAPER | BOARD |
PATENT OWNER'S RESPONSE TO PETITIONER'S NOTICE | Aug 12, 2019 | PAPER | PATENT OWNER |
Petitioner's Notice | Aug 5, 2019 | PAPER | PETITIONER |
Order Conduct of the Proceeding | Aug 1, 2019 | PAPER | BOARD |
PATENT OWNER'S NOTICE OF TRIAL DATE IN THE TEVA CASE | Jul 22, 2019 | PAPER | PATENT OWNER |
Opiant2005 Belz 2006 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2006 Buajordet 2004 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2010 Gaddis 1992 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2014 Letter from Ten Congressmen | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2001 Williams Decl | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2002 Amphastar Press Release | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2003 Aquina 2009 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2004 Baca 2005 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2007 Burford Press Release | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2008 EVZIO Prescribing Information | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2009 FDA Teva Press Release | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2011 Goldfranks | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2012 Indivior Press Release | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2013 Kelly 2002 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2015 Loimer 1992 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2016 Narcan Nasal Spray Prescribing Information | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2017 Osterwalder 1996 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2018 Pallasch 1981 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2019 Popper 1989 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2020 Schwartz 1987 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2021 Sporer 1996 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2022 Sporer 2007 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2023 Stoove 2009 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2024 Terman 2012 Slides | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2025 Teva Case Claim Construction Opinion | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2026 Teva Case Schedule Stipulation | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2027 van Dorp 2007 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2028 Walley 2013 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2030 Wermeling 354 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2031 Williams 2019 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2032 Yealy 1990 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2033 Zuckerman 2014 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2029 Wermeling 2015 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
Opiant2034 US9211253 | Jun 10, 2019 | EXHIBIT | PATENT OWNER |
PRELIMINARY RESPONSE OF PATENT OWNER OPIANT PHARMACEUTICALS, INC. | Jun 10, 2019 | PAPER | PATENT OWNER |
POWER OF ATTORNEY FOR OPIANT PHARMACEUTICALS, INC. | Mar 12, 2019 | PAPER | PATENT OWNER |
MANDATORY NOTICES OF PATENT OWNER OPIANT PHARMACEUTICALS, INC. | Mar 12, 2019 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | Mar 8, 2019 | PAPER | BOARD |
Petition | Feb 19, 2019 | PAPER | PETITIONER |
Power of Attorney | Feb 19, 2019 | PAPER | PETITIONER |
Nalox1001 U. S. Patent 9,468,747 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1002 Donovan Declaration - 688 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1003 Hochhaus Declaration - 688 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1005 FH 15/183,441 Excerpt - Oct. 21, 2016 Resp. | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1004 FH 15/183,441 Excerpt - Aug. 22, 2016 Action | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1007 U.S. Patent No. 9,192,570 (Wyse) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1009 WO 00/62,757 (Davies) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1012 Handbook of Pharmaceutical Excipients | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1013 Kushwaha (2011) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1015 U.S. Patent No. 8,198,291 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1008 Chinese Patent No. 1,575,795 (Wang) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1010 Djupesland (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1011 Grassin-Delyle (2012) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1014 U.S. Patent No. 5,866,154 (Bahal) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1016 Wermeling (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1018 APTAR Press Release | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1017 Alabama EMS Protocols (2013) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1019 Ashton (2006) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1023 Boyer (2012) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1025 Commonwealth Kentucky Patient Care Protocols (2015) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1027 Dowling (2008) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1028 2002 FDA Guidance | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1029 2003 FDA Guidance | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1032 Hertz Presentation | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1034 Kelly (2005) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1020 Barton (2002) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1021 Barton (2005) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1022 Bitter (2011) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1024 CDC - Zomig Review | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1026 Costantino (2007) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1030 Freise (2012) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1031 Glende (2016) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1036 Kerr (2009) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1037 Kleiman-Wexler (1989) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1042 Monitto (2011) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1043 Lemke (2008) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1044 PDR (2003) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1046 Robertson (2005) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1035 Kerr (2008) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1038 Marple (2004) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1039 Merck Index | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1040 Merlin (2010) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1041 Middleton (2011) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1045 PDR (2010) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1047 Robertson (2009) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1049 Role of Naloxone (Full Transcript) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1050 Rosanske (1986) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1053 Trows (2014) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1054 USP 36-NF 31 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1056 U.S. Patent No. 5,307,953 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1057 U.S. Patent No. 5,813,570 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1058 U.S. Provisional Patent App. 61/953379 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1059 Wermeling (2010) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1060 Loimer (1994) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1048 Role of Naloxone (76 Fed Reg. 71,348) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1051 Sabzghabaee (2014) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1055 U.S. Patent Appl. No. 61/918,802 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1061 Doe-Simkins (2009) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1062 McDermott (2012) | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1063 Notice of Allowance from USP 9,468,747 FH | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1064 Butler Affidavit | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1065 Wisconsin Affidavit_Part 1 of 2 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1066 Lipscomb Affidavit | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1065 Wisconsin Affidavit_Part 2 of 2 | Feb 19, 2019 | EXHIBIT | PETITIONER |
Nalox1006 FH 15/183,441 Excerpt - Dec. 21, 2016 NOA | Feb 19, 2019 | EXHIBIT | PETITIONER |